A total of four studies fulfilled the inclusion criteria, of which only two were of high methodologic quality. In all studies, the sensitivity of colposcopy was lower than that of cytology. In three studies the specificity of colposcopy was lower than that of cytology, in one study specificity of colposcopy and cytology was similar. No health economic data suggesting positive effects of adding colposcopy in primary screening could be identified.
Results
A total of four studies fulfilled the inclusion criteria, of which only two were of high methodologic quality. In all studies, the sensitivity of colposcopy was lower than that of cytology. In three studies the specificity of colposcopy was lower than that of cytology, in one study specificity of colposcopy and cytology was similar. No health economic data suggesting positive effects of adding colposcopy in primary screening could be identified.
Discussion
Only few studies have compared the test criteria of colposcopy with those of cytology for screening in cervical cancer. In all studies, sensitivity of colposcopy was even lower than the sensitivity of cytology, which has been critisized because of its low sensitivity.
Conclusion
Based on the present data, an inclusion of colposcopy in primary cervical cancer screening programmes can not be recommended. 
Zusammenfassung Einleitung

Objectives 2.1 Medical questions
How does colposcopy compare to cytology in terms of sensitivity and specificity, and what may be implications for primary screening for cervical carcinoma in Germany?
Economic questions
Is there health economic evidence that may foster an inclusion of colposcopy into national screening programms?
Methods
A systematic literature review was performed, including studies that compared colposcopy to cervical cytology in terms of sensitivity and specificity. Studies that directly compared the sensitivity and specificity of colposcopy and cytology for detecting precancerous lesions in normal-risk populations were included. In addition, a systematic review of the relevant health economic literature was performed to analyse cost-effectiveness issues relevant to the German setting.
Results
We identified 406 medical, 110 economic studies, 23 articles on ethics and 43 HTA reports. Based on title and abstract, 36 medical studies were reviewed in detail. All those, four studies fulfilled the inclusion criteria, of which only two were of high methodologic quality. In all studies, sensitivity of colposcopy was lower than that of cytology. In three studies the specificity of colposcopy was lower than that of cytology, in one study specificity of colposcopy and cytology was similar (Table 1 ) .
Discussion
Only few studies have compared the test criteria of colposcopy with those of cytology for the primary screening in cervical cancer. In all studies, sensitivity of colposcopy was even lower than the sensitivity of cytology, which has been criticised because of its low sensitivity.
Ethical/social/legal considerations
No relevant studies could be identified.
Conclusion
Based on present data, an inclusion of colposcopy as a primary tool in cervical cancer screening programmes can not be recommended.
Kurzfassung 1. Einleitung
In 
Diskussion
Der Mangel an geeigneten Studien erschwert eine Beantwortung der Fragestellungen dieses Berichts. Angesichts der Ergebnisse der vorliegenden Studien und der aktuellen Diskussion um eine Ersetzung oder Ergänzung der zytologischen Tests durch Tests auf das humane Papillomavirus (HPV) -wofür eine Reihe von hochwertigen Studien vorliegen -kann eine Integration der Kolposkopie in ein primäres Screening auf das Zervixkarzinom nicht empfohlen werden.
Ethische/soziale/juristische Aspekte
Es konnten keine relevanten Studien identifiziert werden.
Schlussfolgerung
Aufgrund der vorliegenden Studien kann die Kolposkopie nicht zum Einsatz im primären Screening auf das Zervixkarzinom empfohlen werden.
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